FDA Approved: * September 10, 1987 Pharm Company: *IVAX PHARMS Category:Antipsychotic
Perphenazine is a typical antipsychotic drug. Chemically, it is classified as a piperazinyl phenothiazine. Originally marketed in the United States as Trilafon, it has been in clinical use for decades.
Perphenazine is roughly ten times as potent as chlorpromazine at the dopamine-2 (D2) receptor; thus perphenazine is considered a medium-potency antipsychotic.
1 Medical uses
2 Side effects
* May have multiple approval dates, manufacturers, or labelers. 16 Discussions